A fluorescent ligand-binding alternative using Tag-lite® technology. - Wikidata - wikimedia - TriplyDB

A fluorescent ligand-binding alternative using Tag-lite® technology.

A fluorescent ligand-binding alternative using Tag-lite® technology.

http://www.wikidata.org/entity/Q51771172

about

Large-scale production and protein engineering of G protein-coupled receptors for structural studies Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling.Fragment screening at adenosine-A(3) receptors in living cells using a fluorescence-based binding assay.A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor.Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)Portraying G protein-coupled receptors with fluorescent ligands Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues.Establishment of a novel cell-based assay for screening small molecule antagonists of human interleukin-6 receptor.Application of BRET to monitor ligand binding to GPCRs.Target engagement and drug residence time can be observed in living cells with BRET.Vasopressin inhibits LTP in the CA2 mouse hippocampal area.Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats HIV cell fusion assay: phenotypic screening tool for the identification of HIV entry inhibitors via CXCR4.GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding.Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement.Monitoring Gq-coupled receptor response through inositol phosphate quantification with the IP-One assay.An update of novel screening methods for GPCR in drug discovery.Measurement of G protein-coupled receptor surface expression.Evolution of biologics screening technologies.EuroTracker® dyes: design, synthesis, structure and photophysical properties of very bright europium complexes and their use in bioassays and cellular optical imaging.Rational design of CXCR4 specific antibodies with elongated CDRs.RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia.A Broad G Protein-Coupled Receptor Internalization Assay that Combines SNAP-Tag Labeling, Diffusion-Enhanced Resonance Energy Transfer, and a Highly Emissive Terbium Cryptate.Drug discovery opportunities and challenges at g protein coupled receptors for long chain free Fatty acids.A homogeneous single-label quenching resonance energy transfer assay for a δ-opioid receptor-ligand using intact cells.Fluorescent ligands for G protein-coupled receptors: illuminating receptor-ligand interactions for drug discovery.Original Fluorescent Ligand-Based Assays Open New Perspectives in G-Protein Coupled Receptor Drug Screening.Time-resolved fluorescence ligand binding for G protein-coupled receptors.Versatility of homogeneous time-resolved fluorescence resonance energy transfer assays for biologics drug discovery.Creating infinite contrast in fluorescence microscopy by using lanthanide centered emission.A Time-Resolved FRET Cell-Based Binding Assay for the Apelin Receptor.Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination.Convenient Access to Fluorescent Probes by Chemoselective Acylation of Hydrazinopeptides: Application to the Synthesis of the First Far-Red Ligand for Apelin Receptor Imaging.

P2860

Q26866010-52068BA2-6DCC-4C9E-A50C-FBD9D6EFC6AF Q27004213-25C7D357-0C8D-4850-9045-1F41424B75E2 Q28067465-3EB86961-2EC7-4B30-940C-12513EE08268 Q28480517-AAC73836-DA0A-423A-99B9-E79DC4B4426B Q30420969-AD80CD70-B98C-46FD-9601-7DA933937289 Q31100553-1D9F0478-3A04-481D-8CAD-ED293754485D Q31120649-FC827933-31DD-41D2-9B7A-97D280C2B032 Q33924007-9994DE83-D64E-4958-8ABD-961071A8118B Q34211605-E86B4826-2320-4A55-8543-C2A1FB0FD1F8 Q34243587-A9DC8CAD-FD77-4B51-8FC9-AFFE738FEFBA Q34257617-89D00549-D863-4E8C-9B0F-19022E426BCD Q34290644-F50AB9D4-3A27-4561-AE03-043EEB17A7BC Q34451985-6446813C-0E07-4ED5-9C6F-259610B98B74 Q34478715-3C624991-D51C-438A-9418-4C295FB568AC Q34503961-E43435BB-7F0D-4202-8F40-171FD3A29F3E Q34510263-CD56EB3C-3F56-44D6-AFFB-4A55F7B65DAC Q34818322-40F98CDA-8F1B-4BC8-AB4D-5EB5F8C4C0A5 Q34976806-E1470FCC-15D0-4920-B3E8-56B028C21212 Q35048339-54D6EE13-B5CA-4B9E-A2B7-C95DCB50842A Q35227508-980D6E15-0B8C-4E85-B7D3-25621792CFD7 Q37446861-63CE290E-172D-41AB-B017-F502C7D74A40 Q37642643-C764C64F-B204-444A-AAD5-F96C047D31DF Q38014554-62FAA65F-824A-49E5-A596-396A0DD2C0D9 Q38020237-338E1D90-B345-4A85-827D-FBD5633DA612 Q38096004-1E4A8083-117C-415A-AD81-8B05529965F0 Q38166225-083DE3ED-AF8F-4AE0-86C6-E8E991B3E05D Q38262236-72FE6688-3FEF-4674-8682-57C21715F8AA Q38973911-D5D7DD54-8AB9-4393-A15B-FE506F1792F7 Q41075047-0D984BCE-A92B-453B-A79E-D93047FC71EB Q41843794-A57D9ADD-D77F-4B7A-9C84-E5FAC558F91A Q42174959-3E983CC1-BA29-4B9C-AFD8-316F4C2918AA Q44340063-49ACEA63-AE41-47BF-A9CB-F6EFDD691D43 Q44404761-5D493D6D-203B-4E63-8CB9-D3AE1614C44B Q45842287-9C0EAC74-4330-4B9A-AE4D-207E326BD8F4 Q46520207-47796406-77A6-4D4F-84BD-920951590CCC Q46816575-23BF48D4-1793-4BBD-8E2B-D122CF119115 Q47126945-74F27440-5D98-4704-9150-10624D9E8107 Q48042757-2CFF1F5D-865A-4D04-8164-AE3363CE459A Q48184079-202D5FE5-08A1-4769-AF1B-DF2DDD5FDF9A Q48278244-7332426F-36F1-41E3-A6EA-E7564BA2C129

P2860

A fluorescent ligand-binding alternative using Tag-lite® technology.

http://www.wikidata.org/entity/Q51771172

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

A fluorescent ligand-binding alternative using Tag-lite® technology.

@en

A fluorescent ligand-binding alternative using Tag-lite® technology.

@nl

type

label

A fluorescent ligand-binding alternative using Tag-lite® technology.

@en

A fluorescent ligand-binding alternative using Tag-lite® technology.

@nl

prefLabel

A fluorescent ligand-binding alternative using Tag-lite® technology.

@en

A fluorescent ligand-binding alternative using Tag-lite® technology.

@nl

P1433

Q51771172-3118A83F-E7C9-4387-A867-394B761645D3

P1476

Q51771172-19FA4A4E-14E7-4512-B5D2-5D7DB6E50893

P2093

Q51771172-06118716-D026-4DE2-9387-2B8195D0C7CF

Q51771172-122CE6ED-6250-4877-BC46-771EC0DC4BA7

Q51771172-1C42DACC-F625-4B2B-94F4-3152D02821E2

Q51771172-4B864908-8B6B-4483-922C-7EA830EC4BFB

Q51771172-5C8909F8-A637-4671-A6D6-E3A8E7231DD7

Q51771172-646D0A45-310F-47FB-BEC0-D4BA1269CE86

Q51771172-6682B6C5-D462-43F7-9197-8839476E915D

Q51771172-69678E3A-41AE-4C94-89C8-88A587354ECA

Q51771172-70B1B4E6-51D6-4BB5-9CCF-74F5FE5C43AD

Q51771172-73B8A6BD-522C-498C-834B-076989F73880

P304

Q51771172-B57D58E2-3FF1-4696-99F7-9C1D3F23CEF7

P31

Q51771172-F4E63045-176E-42BF-B508-CFEAFC90857F

P356

Q51771172-F2994A9E-3F19-4355-AD52-1FDBEAE18F44

P433

Q51771172-3321F5C3-A532-4B52-8F70-19DECE14516F

P478

Q51771172-22940056-5DE4-43AD-BC8F-E106B2C82740

P577

Q51771172-DB5005E4-3AB1-459D-8B52-7FF0B81F8F39

P5875

Q51771172-CD3EB7D7-7482-495D-B2B1-0959DB7CDCCA

P698

Q51771172-68271339-6FFB-4083-B4C9-584997139846

P921

Q51771172-FF1A35DE-F2DB-49E7-B770-7DF198337AC6

P356

1087057110384611

P1433

Journal of Biomolecular Screening

P1476

A fluorescent ligand-binding alternative using Tag-lite® technology.

@en

P2093

Chloe Boisseau

http://www.w3.org/2001/XMLSchema#string

Emmanuel Bourrier

http://www.w3.org/2001/XMLSchema#string

Eric Trinquet

http://www.w3.org/2001/XMLSchema#string

Fabienne Charrier-Savournin

http://www.w3.org/2001/XMLSchema#string

Jurriaan M Zwier

http://www.w3.org/2001/XMLSchema#string

Ludovic Nicolas

http://www.w3.org/2001/XMLSchema#string

Martin Cottet

http://www.w3.org/2001/XMLSchema#string

Michel Fink

http://www.w3.org/2001/XMLSchema#string

Nadia Oueslati

http://www.w3.org/2001/XMLSchema#string

Nathalie Gregor

http://www.w3.org/2001/XMLSchema#string

P304

1248-1259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1087057110384611

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47544340

http://www.w3.org/2001/XMLSchema#string

P698

20974902

http://www.w3.org/2001/XMLSchema#string

P921